• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

机器学习驱动的1型糖尿病成年患者合并症及死亡率预测

Machine Learning-Driven Prediction of Comorbidities and Mortality in Adults With Type 1 Diabetes.

作者信息

Andersen Jonas Dahl, Stoltenberg Carsten Wridt, Jensen Morten Hasselstrøm, Vestergaard Peter, Hejlesen Ole, Hangaard Stine

机构信息

Department of Health Science and Technology, Aalborg University, Aalborg, Denmark.

Steno Diabetes Center North Denmark, Aalborg, Denmark.

出版信息

J Diabetes Sci Technol. 2024 Aug 2:19322968241267779. doi: 10.1177/19322968241267779.

DOI:10.1177/19322968241267779
PMID:39091237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11571562/
Abstract

BACKGROUND

Comorbidities such as cardiovascular disease (CVD) and diabetic kidney disease (DKD) are major burdens of type 1 diabetes (T1D). Predicting people at high risk of developing comorbidities would enable early intervention. This study aimed to develop models incorporating socioeconomic status (SES) to predict CVD, DKD, and mortality in adults with T1D to improve early identification of comorbidities.

METHODS

Nationwide Danish registry data were used. Logistic regression models were developed to predict the development of CVD, DKD, and mortality within five years of T1D diagnosis. Features included age, sex, personal income, and education. Performance was evaluated by five-fold cross-validation with area under the receiver operating characteristic curve (AUROC) and the precision-recall area under the curve (PR-AUC). The importance of SES was assessed from feature importance plots.

RESULTS

Of the 6572 included adults (≥21 years) with T1D, 379 (6%) developed CVD, 668 (10%) developed DKD, and 921 (14%) died within the five-year follow-up. The AUROC (±SD) was 0.79 (±0.03) for CVD, 0.61 (±0.03) for DKD, and 0.87 (±0.01) for mortality. The PR-AUC was 0.18 (±0.01), 0.15 (±0.03), and 0.49 (±0.02), respectively. Based on feature importance plots, SES was the most important feature in the DKD model but had minimal impact on models for CVD and mortality.

CONCLUSIONS

The developed models showed good performance for predicting CVD and mortality, suggesting they could help in the early identification of these outcomes in individuals with T1D. The importance of SES in individual prediction within diabetes remains uncertain.

摘要

背景

心血管疾病(CVD)和糖尿病肾病(DKD)等合并症是1型糖尿病(T1D)的主要负担。预测有发生合并症高风险的人群将有助于早期干预。本研究旨在开发纳入社会经济地位(SES)的模型,以预测成年T1D患者的CVD、DKD和死亡率,从而改善合并症的早期识别。

方法

使用丹麦全国登记数据。建立逻辑回归模型以预测T1D诊断后五年内CVD、DKD的发生及死亡率。特征包括年龄、性别、个人收入和教育程度。通过五折交叉验证,利用受试者工作特征曲线下面积(AUROC)和精确召回率曲线下面积(PR-AUC)评估模型性能。从特征重要性图评估SES的重要性。

结果

在纳入的6572名年龄≥21岁的成年T1D患者中,379人(6%)发生CVD,668人(10%)发生DKD,921人(14%)在五年随访期内死亡。CVD的AUROC(±标准差)为0.79(±0.03),DKD为0.61(±0.03),死亡率为0.87(±0.01)。PR-AUC分别为0.18(±0.01)、0.15(±0.03)和0.49(±0.02)。基于特征重要性图,SES是DKD模型中最重要的特征,但对CVD和死亡率模型的影响最小。

结论

所开发的模型在预测CVD和死亡率方面表现良好,表明它们有助于早期识别T1D患者的这些结局。SES在糖尿病个体预测中的重要性仍不确定。

相似文献

1
Machine Learning-Driven Prediction of Comorbidities and Mortality in Adults With Type 1 Diabetes.机器学习驱动的1型糖尿病成年患者合并症及死亡率预测
J Diabetes Sci Technol. 2024 Aug 2:19322968241267779. doi: 10.1177/19322968241267779.
2
Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.机器学习算法在 2 型糖尿病合并糖尿病肾病患者终末期肾病风险预测模型中的开发与内部验证。
Ren Fail. 2022 Dec;44(1):562-570. doi: 10.1080/0886022X.2022.2056053.
3
Development and External Validation of Machine Learning Models for Diabetic Microvascular Complications: Cross-Sectional Study With Metabolites.机器学习模型在糖尿病微血管并发症中的开发和外部验证:基于代谢物的横断面研究。
J Med Internet Res. 2024 Mar 28;26:e41065. doi: 10.2196/41065.
4
Prediction and Risk Stratification of Cardiovascular Disease in Diabetic Kidney Disease Patients.糖尿病肾病患者心血管疾病的预测与风险分层
Front Cardiovasc Med. 2022 Jun 24;9:923549. doi: 10.3389/fcvm.2022.923549. eCollection 2022.
5
Interpretable machine learning models based on shear-wave elastography radiomics for predicting cardiovascular disease in diabetic kidney disease patients.基于剪切波弹性成像放射组学的可解释机器学习模型预测糖尿病肾病患者心血管疾病
J Diabetes Investig. 2024 Nov;15(11):1637-1650. doi: 10.1111/jdi.14294. Epub 2024 Aug 22.
6
A Machine Learning Model for Risk Stratification of Postdiagnosis Diabetic Ketoacidosis Hospitalization in Pediatric Type 1 Diabetes: Retrospective Study.用于1型糖尿病儿童诊断后糖尿病酮症酸中毒住院风险分层的机器学习模型:回顾性研究
JMIR Diabetes. 2024 Aug 7;9:e53338. doi: 10.2196/53338.
7
A Risk Prediction Model for Physical Restraints Among Older Chinese Adults in Long-term Care Facilities: Machine Learning Study.长期护理机构中老年人身体约束的风险预测模型:机器学习研究。
J Med Internet Res. 2023 Apr 6;25:e43815. doi: 10.2196/43815.
8
Unveiling the utility of artificial intelligence for prediction, diagnosis, and progression of diabetic kidney disease: an evidence-based systematic review and meta-analysis.揭示人工智能在糖尿病肾病预测、诊断和病情进展方面的效用:一项基于证据的系统评价和荟萃分析。
Curr Med Res Opin. 2024 Dec;40(12):2025-2055. doi: 10.1080/03007995.2024.2423737. Epub 2024 Nov 13.
9
A 10-year retrospective cohort of diabetic patients in a large medical institution: Utilizing multiple machine learning models for diabetic kidney disease prediction.一家大型医疗机构中糖尿病患者的10年回顾性队列研究:利用多种机器学习模型预测糖尿病肾病
Digit Health. 2024 Jul 21;10:20552076241265220. doi: 10.1177/20552076241265220. eCollection 2024 Jan-Dec.
10
Association of Diabetic Retinopathy and Diabetic Kidney Disease With All-Cause and Cardiovascular Mortality in a Multiethnic Asian Population.在一个多民族亚洲人群中,糖尿病视网膜病变和糖尿病肾病与全因和心血管死亡率的关系。
JAMA Netw Open. 2019 Mar 1;2(3):e191540. doi: 10.1001/jamanetworkopen.2019.1540.

本文引用的文献

1
Understanding random resampling techniques for class imbalance correction and their consequences on calibration and discrimination of clinical risk prediction models.理解随机重采样技术在类别不平衡校正中的应用及其对临床风险预测模型校准和区分的影响。
J Biomed Inform. 2024 Jul;155:104666. doi: 10.1016/j.jbi.2024.104666. Epub 2024 Jun 6.
2
TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods.TRIPOD+AI 声明:报告使用回归或机器学习方法的临床预测模型的更新指南。
BMJ. 2024 Apr 16;385:e078378. doi: 10.1136/bmj-2023-078378.
3
Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available data.利用公共可用数据上的人工智能辅助实施 1 型糖尿病筛查。
Diabetologia. 2024 Jun;67(6):985-994. doi: 10.1007/s00125-024-06089-5. Epub 2024 Feb 14.
4
Development and Validation of a Machine Learning Model to Predict Weekly Risk of Hypoglycemia in Patients with Type 1 Diabetes Based on Continuous Glucose Monitoring.基于持续葡萄糖监测的1型糖尿病患者低血糖每周风险预测机器学习模型的开发与验证
Diabetes Technol Ther. 2024 Jul;26(7):457-466. doi: 10.1089/dia.2023.0532. Epub 2024 May 29.
5
Evaluation of clinical prediction models (part 1): from development to external validation.临床预测模型的评估(第 1 部分):从建立到外部验证。
BMJ. 2024 Jan 8;384:e074819. doi: 10.1136/bmj-2023-074819.
6
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2024.10. 心血管疾病与风险管理:2024年糖尿病护理标准。
Diabetes Care. 2024 Jan 1;47(Suppl 1):S179-S218. doi: 10.2337/dc24-S010.
7
11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2024.11. 慢性肾脏病与风险管理:2024年糖尿病护理标准
Diabetes Care. 2024 Jan 1;47(Suppl 1):S219-S230. doi: 10.2337/dc24-S011.
8
Diabetes and artificial intelligence beyond the closed loop: a review of the landscape, promise and challenges.糖尿病与闭环之外的人工智能:现状、前景与挑战综述。
Diabetologia. 2024 Feb;67(2):223-235. doi: 10.1007/s00125-023-06038-8. Epub 2023 Nov 18.
9
Predicting the Risk of Developing Type 1 Diabetes Using a One-Week Continuous Glucose Monitoring Home Test With Classification Enhanced by Machine Learning: An Exploratory Study.使用基于机器学习的分类增强的一周连续血糖监测家庭测试预测 1 型糖尿病发病风险:一项探索性研究。
J Diabetes Sci Technol. 2024 Mar;18(2):257-265. doi: 10.1177/19322968231209302. Epub 2023 Nov 9.
10
Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine.关于精准糖尿病医学临床转化的差距与机遇的第二份国际共识报告
Nat Med. 2023 Oct;29(10):2438-2457. doi: 10.1038/s41591-023-02502-5. Epub 2023 Oct 5.